viernes, 17 de noviembre de 2023

FDA approves capivasertib with fulvestrant for breast cancer

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-capivasertib-fulvestrant-breast-cancer?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario